Day: December 28, 2022

Osisko Provides Update on CSA Stream Transaction

Osisko Provides Update on CSA Stream Transaction

MONTRÉAL, Dec. 28, 2022 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to announce that its wholly-owned subsidiary, Osisko Bermuda Limited (“OBL”), has entered into a revised binding agreement with Metals Acquisition Corp. (“MAC”) (MTAL: NYSE) with respect to the purchase of a 100% silver stream (the “Silver Stream”) on the producing CSA mine in New South Wales, Australia (“CSA” or the “Mine”) to partially fund MAC’s acquisition of the Mine. MAC has filed a preliminary Form F-4 with the U.S. Securities and Exchange Commission for their review purposes, which includes, among other things, details of its proposed acquisition of 100% of the shares of the owner of CSA from a subsidiary of Glencore plc (the “Acquisition Transaction”).   Separately, OBL and MAC have entered...

Continue reading

Purpose Investments Inc. Announces Revision to December 2022 Distribution Rate for Purpose US Cash Fund

Purpose Investments Inc. Announces Revision to December 2022 Distribution Rate for Purpose US Cash Fund

TORONTO, Dec. 28, 2022 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today a revision to the December 2022 distribution for Purpose US Cash Fund (ETF ticker: PSU.U). The press release on December 19, 2022, reported a distribution of US $0.4015 per unit. The revised distribution rate for PSU.U will be US $0.3775 per unit. The ex-distribution date, record date, and payable dates for the distribution remain unchanged. The following table reflects the revised distribution per unit: Open-End Fund Ticker Symbol Distribution per unit Record Date Payable Date Distribution Frequency Purpose US Cash Fund – ETF Units PSU.U US$ 0.3775 12/30/2022 01/09/2023 Monthly About Purpose Investments Inc. Purpose Investments Inc. is an asset management company with more than $14 billion in assets under management. Purpose Investments has...

Continue reading

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference. Brian McKelligon, CEO, is scheduled to present on Wednesday, January 11th, 2023 at 9:45 a.m. PT. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/. About Akoya BiosciencesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence...

Continue reading

Richardson Electronics Announces Date of Second Quarter Fiscal Year 2023 Conference Call

Richardson Electronics Announces Date of Second Quarter Fiscal Year 2023 Conference Call

LAFOX, Ill., Dec. 28, 2022 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for its second quarter ended November 26, 2022 after the close of business on Wednesday, January 4, 2023. The release will be distributed by GlobeNewswire and will be available on the Company’s website at www.rell.com. On Thursday, January 5, 2023, at 9:00 a.m. Central Time, Edward J. Richardson, Chairman and Chief Executive Officer, and Robert J. Ben, Chief Financial Officer, will host a conference call to discuss the Company’s second quarter fiscal year 2023 results. A question-and-answer session will be included as part of the call’s agenda. Participant Instructions Participants may register for the call here. While not required, it is recommended you join 10 minutes prior to the event start. A replay...

Continue reading

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was to Participate in the ICR Conference 2023

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was to Participate in the ICR Conference 2023

ATLANTA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE: OXM) today announced the Company will be presenting at the ICR Conference 2023 being held at the JW Marriott Orlando Grande Lakes in Orlando, Florida. Tom Chubb, Chairman, CEO and President of Oxford will present at 3:00 p.m. Eastern Time on Monday, January 9, 2023. The presentation will be webcast and can be accessed via the Oxford website at www.oxfordinc.com. About Oxford Oxford Industries, Inc., a leader in the apparel industry, owns and markets the distinctive Tommy Bahama®, Lilly Pulitzer®, Johnny Was®, Southern Tide®, The Beaufort Bonnet Company®, and Duck Head® lifestyle brands. Oxford’s stock has traded on the New York Stock Exchange since 1964 under the symbol OXM. For more information, please visit Oxford’s website at www.oxfordinc.com. Contact: Jevon...

Continue reading

Stryker to host conference call on January 31, 2023

Stryker to host conference call on January 31, 2023

Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker’s Q4 and Full Year 2022 Earnings Call.  After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a day in advance or a minimum of 15 minutes before...

Continue reading

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) — (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, January 11, 2023, at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/. About RxSight, Inc.RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories,...

Continue reading

Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S from The Nasdaq Stock Market

Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S from The Nasdaq Stock Market

NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan Holdings Corp. II. Tuscan Holdings Corp. II’s securities were suspended on November 21, 2022, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Clovis Oncology, Inc. Clovis Oncology, Inc.’s securities were suspended on December 21, 2022, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the warrants of ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.’s warrants were suspended on December 21, 2022, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock of Otonomy, Inc. Otonomy, Inc.’s securities were suspended on...

Continue reading

Canadian Spirit Resources Inc. Resumes Production at Farrell Creek, Northeast British Columbia

Canadian Spirit Resources Inc. Resumes Production at Farrell Creek, Northeast British Columbia

CALGARY, Alberta, Dec. 28, 2022 (GLOBE NEWSWIRE) — Canadian Spirit Resources Inc. (“CSRI” or the “Corporation”) (TSXV:SPI) (OTCBB:CSPUF) is pleased to announce that production from its joint venture Montney wells at Farrell Creek/Altares was restarted on December 16, 2022. The Farrell Creek natural gas processing facility and associated Montney wells experienced a shut down related to cold weather on November 9, 2022. Current average production is approximately 5.0 Mmcf/d with CSRI’s 35% share being approximately 1.75 Mmcf/d. Information regarding CSRI is available on SEDAR at www.sedar.com or the Corporation’s website at www.csri.ca. For further information, please contact: Canadian Spirit Resources Inc.Telephone (403) 618-2113Louisa DeCarlo (louisa@danrichresources.com) Forward-looking Information Cautionary Statement This press...

Continue reading

European Energy A/S: Sale of a solar park in Denmark with a total capacity of 55 MW completed

European Energy A/S: Sale of a solar park in Denmark with a total capacity of 55 MW completed

Company announcement 19/2022 (28.12.2022) Today, European Energy has completed the sale of a solar park in Denmark with a total capacity of 55 MW. European Energy’s financial guidance for 2022 remains unchanged at an EBITDA of EUR 135m and profit before tax of EUR 100m. For further information, please contact Investor Relations: investor.relations@europeanenergy.com. This announcement has been made in accordance with the market abuse regulation (regulation (EU) no. 596/2014 on market abuse).

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.